Ospitek Gets HealthpointCapital Backing for Surgical Flow

A patient's family has a place inside Ospitek's operating model. The San Diego surgical software company describes a system that follows patient movement and shares updates with staff, administrators and the people waiting for news about someone they love. Giving those audiences useful information from the same journey makes surgical coordination a broader business than a better scheduling screen.

HealthpointCapital announced an investment in Ospitek on October 13, 2026, with financial terms undisclosed. The musculoskeletal healthcare private equity firm plans to support the technology platform, commercial organization, customer success and product innovation. CEO and cofounder Dr. Slim Souissi says the partnership will help bring Ospitek to more surgical facilities across the US.

The investment puts specialized healthcare capital behind the coordination surrounding a procedure. Ospitek sells visibility across the surgical episode, while its new investor already backs technology for moving instruments through surgical facilities. For ambulatory surgery centers, the operating consequence reaches into how people, patients and equipment share a working day.

HealthpointCapital is investing across the surgical day

HealthpointCapital's Ospitek portfolio record identifies an active investment made in October 2026 and confirms the company's San Diego headquarters. The announcement gives no amount, valuation, ownership percentage or financing instrument. An investment has been announced; assigning a Series A label or describing a majority acquisition would add information the parties have kept private.

Managing Partner Mike Mogul brings experience running the businesses that sell into this environment. His official biography lists former roles as CEO of DJO Global and group president overseeing Stryker's orthopaedic businesses. That background gives the firm's specialization a concrete commercial foundation: familiarity with surgical customers, their purchasing relationships and the operational demands around musculoskeletal care.

The firm's separate investment in SteriCUBE addresses instrument sterilization and flow. Ospitek addresses the information following patients. The two holdings place HealthpointCapital around different dependencies in surgical delivery, though no combined product or integration agreement was announced. A facility can have an available room and still need people, instruments or a patient to be ready; the investor's portfolio now touches more of that coordination.

This is a useful lens on the deal's commercial logic. Capacity depends on the sequence in which a facility's resources become available, and better visibility can help teams examine that sequence. Whether customers translate those observations into durable improvements belongs to the work inside each facility.

Wireless engineering meets surgical experience at Ospitek

Ospitek's leadership page identifies three cofounders: Dr. Slim Souissi, Don Courtney and Dr. Munish Batra. The company lists Dr. Michael Ast as CMO and Heithem Souissi as VP of Product Engineering. Those roles put clinical and technical experience near the software's development without requiring a fictional founder origin story to make the pairing interesting.

Slim Souissi's company biography describes a career in wireless technology, including former CTO and president/COO roles at Novatel Wireless. It also credits work on mobile broadband and the MiFi hotspot. Bringing that experience into surgical operations shifts the audience for connected-device information: the people who need a useful signal include clinicians and family members with very different responsibilities.

Munish Batra's biography identifies him as a plastic and reconstructive surgeon. Don Courtney's biography describes business-development experience across healthcare and wireless tracking. The biographies help explain the mix of capabilities around Ospitek; they do not establish that every product claim has been independently validated.

The company reports a 2018 founding date on its LinkedIn page. Its public materials describe customers across ambulatory surgery centers and surgical hospitals, but the investment announcement offers no audited facility count, revenue or growth percentage. The available company history supports a business already addressing surgical workflows while leaving its financial scale largely private.

The same patient movement serves several audiences

Ospitek calls its platform VIEW in its official video library. The company describes IoT movement sensing, live visualization, automated communication and analytics across the patient journey. Its product materials cover registration, pre-operative preparation, the operating room and recovery, along with analysis by surgeon, procedure and date range.

For staff, a shared view of progress can provide information for coordinating the next step. For administrators, the recorded journey provides material for examining where time went. For families, updates can make a period of waiting more understandable. These are distinct uses of the same underlying movement record, and each places a different expectation on the information presented.

Ospitek positions VIEW as an overlay to existing systems. That deployment choice has commercial significance because the company is selling into facilities with established software and working habits. The description suggests a route to add live operational information around existing workflows; sweeping claims about effortless deployment or guaranteed performance would require evidence beyond the company's marketing materials.

DevCuration's reporting on Intake AI's clinical-trial operations software explores another place where information has to remain useful to the people performing healthcare work. Ospitek's specific case sits around surgical movement and communication. Reading both businesses through their users' responsibilities is more informative than treating healthcare AI as a single product category.

Expansion reaches into implementation and customer support

HealthpointCapital's stated investment priorities include customer success alongside commercial and technology development. For Ospitek, that combination matters because a software sale begins an operating relationship with a surgical facility. Staff have routines, administrators have metrics and families have expectations about communication; implementation has to account for all three audiences.

The public materials supply a concrete product description but little investment-specific outcome data. They leave pricing, spending allocations, hiring targets and expansion timetables unannounced. Buyers can therefore evaluate a defined workflow proposition while asking for facility-level evidence relevant to their own circumstances, including which milestones are captured and how teams use the resulting information.

Other healthcare technology businesses have to earn usefulness within similarly specific settings. Sharp Biomedical's outpatient spine-care work, for example, makes the facility part of its product context. That is a different technology and a separate capital event, but the setting carries commercial weight in both stories: adoption has to fit where the work happens.

Each additional facility will have to decide who sees which milestone, who follows up when movement slows and how the record informs tomorrow's schedule. HealthpointCapital is backing Ospitek as those implementation decisions become part of a larger commercial organization, bringing customer success into the work of making live visibility useful.